<!DOCTYPE html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if gt IE 8]><!-->
<html class="no-js">
<!--<![endif]-->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jspdf/1.0.272/jspdf.debug.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/html2canvas/0.4.1/html2canvas.js"></script>

<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/jspdf/1.2.61/jspdf.min.js"></script>

<head>
<meta http-equiv=Content-Type content="text/html; charset=UTF-8">
<meta name=Generator content="Microsoft Word 14 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
    {font-family:Wingdings;
    panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
    {font-family:Wingdings;
    panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
    {font-family:Calibri;
    panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
    {font-family:Tahoma;
    panose-1:2 11 6 4 3 5 4 4 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
    {margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:12.0pt;
    font-family:"Times New Roman","serif";}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
    {mso-style-link:"Comment Text Char";
    margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:10.0pt;
    font-family:"Times New Roman","serif";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
    {margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:12.0pt;
    font-family:"Times New Roman","serif";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
    {margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:12.0pt;
    font-family:"Times New Roman","serif";}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
    {margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:10.0pt;
    font-family:"Times New Roman","serif";
    font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
    {margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:8.0pt;
    font-family:"Tahoma","sans-serif";}
span.CommentTextChar
    {mso-style-name:"Comment Text Char";
    mso-style-link:"Comment Text";
    font-family:"Times New Roman","serif";}
 /* Page Definitions */
 @page WordSection1
    {size:8.5in 11.0in;
    border:10px solid black;}
div.WordSection1
    {page:WordSection1;
    size:8.5in 11.0in;
@page WordSection2
    {size:8.5in 11.0in;
    }
div.WordSection2
    {page:WordSection2;
    size:8.5in 11.0in;  
 /* List Definitions */
 ol
    {margin-bottom:0in;}
ul
    {margin-bottom:0in;}
-->
</style>
</head>
<body lang=EN-US style='text-justify-trim:punctuation'style="margin-right:.in height:11in;width:8.5in">
<div style="margin-right:.5in;background-color: white" id ="test">
	<p align=right style='margin-top:.5in;text-align:right'><b>NCI reference# ____________</b></p>

<p class=MsoNormal align=center style='margin-bottom:12.0pt;text-align:center'><b>SOFTWARE
TRANSFER AGREEMENT</b></p>

<p class=MsoNormal><span style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:11.0pt;margin-left:.5in'>Provider: National
Cancer Institute (NCI)</p>

<p class=MsoNormal style='margin-bottom:8.0pt;margin-left:.5in; text-decoration:underline'>Recipient: $[Recipient Name]</p> 

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span style='font-size:11.0pt'>WHEREAS,
Provider has certain proprietary software and associated material described
below (hereinafter, collectively referred to as Software)<i>[Describe all
items being transferred such as; software, executable code, source code,
documentation, data and all other associated materials]</i>:</span></p>

<p class=MsoNormal><b><span style='font-size:11.0pt;layout-grid-mode:line;text-decoration:underline'>National
Cancer Institute Dosimetry System for Computed Tomography (NCICT) software (NIH
Ref. No. E-082-2016/0), provided as executable code (source code not provided),
a computer program to assess organ radiation dose exposure for pediatric and
adult patients undergoing computed tomography (CT) examinations as described in
Lee et al. (J Radiol Prot. 2015 Dec;35(4):891-909), including further
improvements thereof, and related documentation </span></b></p>

<p class=MsoNormal><span style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span style='font-size:11.0pt'>and
Provider agrees to transfer such Software to Recipient Investigator, to be used
solely in connection with the following research activity and for the following
reasons (hereinafter Project)<i> [Describe with specificity the scope of use
of Software under this agreement]</i>:</span></p>

<p style='font-size:11.0pt;text-decoration:underline;margin-left:0.5in'><p>$[reason]<br><br>


<p class=MsoNormal><span style='font-size:11.0pt;'>NOW, THEREFORE, in
consideration of the premises and mutual covenants contained herein, the
Provider and Recipient agree as follows: </span></p>

<p class=MsoNormal><span style='font-size:11.0pt;'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:9.0pt;margin-bottom:9.0pt
text-indent:-.25in'><span style='font-size:11.0pt'>1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
style='font-size:11.0pt'>SOFTWARE SHALL NOT BE USED FOR TREATING OR DIAGNOSING
HUMAN SUBJECTS.   </span></p>

<!-- 

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:9.0pt;
margin-left:.5in;text-indent:-.25in'><span style='font-size:11.0pt'>2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
style='font-size:11.0pt'>
-->
<p class=MsoNormal style='font-size:11.0pt;margin-bottom:9.0pt '><span>2.
Recipient will not license or sell or use Software for
commercial purposes or applications.  Recipient Investigator shall retain
control over Software and further will not transfer the Software to individuals
not under Recipient Investigators direct supervision without the advance
written approval of Provider.  Recipient agrees to comply with all regulations
applicable to the Project and the use of the Software. </span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>2.   Recipient
agrees not to copy Software, in whole or in part, except as required for use by
Recipient Investigator for the conduct of the Project. Recipient shall not
modify, extend, decompile, make derivatives of or reverse engineer the Software
without written permission from Provider.</span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>3.   Information
deemed confidential under this Agreement (Confidential Information) shall be
clearly marked CONFIDENTIAL.  Any information that is orally disclosed must
be reduced to writing and marked CONFIDENTIAL by the provider of the
information within thirty (30) days of such disclosure. To the extent permitted
by applicable law, the Recipient agrees to employ all reasonable efforts to
safeguard Providers Confidential Information to ensure that no unauthorized
person shall have access thereto and that no unauthorized copy, publication,
disclosure or distribution, in whole or in part, in any form shall be made.</span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>4.    
In all oral presentations or written publications concerning the Project,
Recipient will acknowledge Providers contribution of Software unless requested
otherwise.  Recipient may publish or otherwise publicly disclose the results of
the Project, but if Provider has given Confidential Information to Recipient,
such public disclosure may be made only after Provider has had 30 days to
review the proposed disclosure, except when a shortened time period under court
order or the Freedom of Information Act pertains.</span></p>

<span style='font-size:11.0pt;font-family:"Times New Roman","serif"'><br
clear=all style='page-break-before:auto'>
</span>


<p class=MsoNormal style='margin-bottom:3.0pt'><span style='font-size:11.0pt'>5.   The
obligations of Recipient under Paragraph 4 above shall not extend to any part
of the Confidential Information:</span></p>

<p class=MsoNormal style='margin-bottom:3.0pt;margin-left:.5in'><span
style='font-size:11.0pt' > (a) that can be demonstrated to have been publicly
known at the time of disclosure; or</span></p>

<p class=MsoNormal style='margin-bottom:3.0pt;margin-left:.5in'><span
style='font-size:11.0pt'>(b) that can be demonstrated to have been properly in
the Recipients possession or that can be demonstrated to have been readily
available to the Recipient from another proper source prior to the disclosure;
or</span></p>

<p class=MsoNormal style='margin-bottom:3.0pt;margin-left:.5in'><span
style='font-size:11.0pt'>(c) that becomes part of the public domain or publicly
known by publication or otherwise, not due to any unauthorized act by the
Recipient or its subsidiaries; or</span></p>

<p class=MsoNormal style='margin-bottom:3.0pt;margin-left:.5in'><span
style='font-size:11.0pt'>(d) that can be demonstrated as independently
developed or acquired by the Recipient without reference to or reliance upon
such information; or</span></p>

<p class=MsoNormal style='margin-bottom:9.0pt;margin-left:.5in'><span
style='font-size:11.0pt'>(e) that is required to be disclosed by law, provided
that the Recipient takes reasonable and lawful actions to avoid and/or minimize
such disclosure.</span></p>

</div>
</body>
</html>
